Insulin-induced vasodilatation: Physiology or pharmacology?

Diabetologia

Volumn 41, Issue 4, 1998, Pages 369-379

  Yki Jarvinen H ^a   Utriainen, T ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Atherosclerosis; Blood vessels; Diabetes mellitus; Endothelium; Glucose; Hypertension; Muscle; Obesity

Indexed keywords

INSULIN;

ATHEROSCLEROSIS; BLOOD VESSEL COMPLIANCE; ENDOTHELIUM; HYPERLIPIDEMIA; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESPONSE; OBESITY; PRIORITY JOURNAL; REVIEW; VASODILATATION;

ANIMALS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; GLUCOSE; HUMANS; HYPERTENSION; INSULIN; INSULIN RESISTANCE; MUSCLE, SKELETAL; REGIONAL BLOOD FLOW; VASODILATION;

EID: 0031920445     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250050919     Document Type: Review

References (107)

1. Andres R, Cader G, Zierler KL (1956) The quantitatively minor role of carbohydrate in oxidative metabolism by skeletal muscle in intact man in the basal state. Measurements of oxygen and glucose uptake and carbon dioxide and lactate production in the forearm. J Clin Invest 35: 671-682
2. Zierler KL (1961) Theory of the use of arteriovenous concentration differences for measuring metabolism in steady-state and non-steady-states. J Clin Invest 40: 2111-2125
3. Rabinowitz D, Zierler KL (1962) Forearm metabolism in obesity and its response to intra-arterial insulin. Characterization of insulin resistance and evidence for adaptive hyperinsulinism. J Clin Invest 41: 2173-2181
4. Andres R, Baltzan MA, Cader G, Zierler KL (1962) Effect of insulin on carbohydrate metabolism and on potassium in the forearm of man. J Clin Invest 41: 108-115
5. Natali A, Santoro D, Palombo C, Cerri M, Ghione M, Ferrannini E (1991) Impaired insulin action on skeletal muscle metabolism in essential hypertension. Hypertension 17: 170-178
6. Yki-Järvinen H, Sahlin K, Ren JM, Koivisto VA (1990) Localization of the rate-limiting defect for glucose disposal in skeletal muscle of insulin-resistant type 1 diabetic patients. Diabetes 39: 157-167
7. DeFronzo RA, Gunnarson R, Björkman O, Olsson M, Wahren J (1985) Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus. J Clin Invest 76: 149-155
8. Laakso M, Edelman SV, Brechtel G, Baron AD (1990) Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. J Clin Invest 85: 1844-1882
9. Baron AD, Brechtel-Hook G, Johnson A, Hardin D (1993) Skeletal muscle blood flow. A possible link between insulin resistance and blood pressure. Hypertension 21: 129-135
10. Baron AD, Laakso M, Brechtel G, Edelman SV (1991) Mechanism of insulin resistance in insulin-dependent diabetes mellitus: a major role for reduced skeletal muscle blood flow. J Clin Endocrinol Metab 73: 637-643
11. Laakso M, Edelman SV, Brechtel G, Baron AD (1992) Impaired insulin-mediated skeletal muscle blood flow in patients with NIDDM. Diabetes 41: 1076-1083
12. Dela F, Larsen JJ, Mikines KJ, Galbo H (1995) Normal effect of insulin to stimulate leg blood flow in NIDDM. Diabetes 44: 221-226
13. Bonadonna RC, Saccomani MP, Seely L et al. (1993) Glucose transport in human skeletal muscle. The in vivo response to insulin. Diabetes 42: 181-198
14. Anderson EA, Hoffmann RP, Balon TW, Sinkey CA, Mark AL (1991) Hyperinsulinemia produces both sympathetic neural activation and vasodilatation in normal humans. J Clin Invest 87: 2246-2252
15. Scherrer U, Randin D, Vollenweider P, Vollenweider L, Nicod P (1994) Nitric oxide release accounts for insulin's vascular effects in humans. J Clin Invest 94: 2511-2515
16. Tack CJ, Lutterman JA, Vervoot G, Thien T, Smits P (1996) Activation of the sodium-potassium pump contributes to insulin-induced vasodilatation in humans. Hypertension 28: 426-432
17. 18F]FDG and positron emission tomography. Diabetes 45: 1471-1477
18. Buchanan TA, Thawani H, Kades W et al. (1993) Angiotensin II increases glucose utilization during acute hyperinsulinemia via a hemodynamic mechanism. J Clin Invest 92: 720-726
19. Utriainen T, Malmström R, Mäkimattila S, Yki-Järvinen H (1995) Methodological aspects, dose-response characteristics and causes of interindividual variation in insulin stimulation of limb blood flow in normal subjects. Diabetologia 38: 555-564
20. Yki-Järvinen H, Young AA, Lamkin C, Foley JE (1987) Kinetics of glucose disposal in whole body and across the forearm in man. J Clin Invest 79: 1713-1719
21. Elder GCB, Bradbury K, Roberts R (1982) Variability of fiber type distributions within human muscles. J Appl Physiol 53: 1473-1480
22. Johnson MA, Polgar J, Weightman D, Appleton D (1973) Data on the distribution of fibre types in thirty-six human muscles. J Neurol Sci 18: 111-129
23. Nuutila P, Knuuti MJ, Heinonen OJ et al. (1994) Different alterations in the insulin-stimulated glucose uptake in the athlete's heart and skeletal muscle. J Clin Invest 93: 2267-2274
24. Raitakari M, Nuutila P, Ruotsalainen U et al. (1996) The relationship between limb and muscle blood flow in man. J Physiol 469: 543-549
25. Utriainen T, Mäkimattila S, Virkamäki A, Lindholm H, Sovijärvi A, Yki-Järvinen H (1996) Physical fitness and endothelial function (nitric oxide synthesis) are independent determinants of insulin-stimulated blood flow in normal subjects. J Clin Endocrinol Metab 81: 4258-4263
26. Utriainen T, Holmäng A, Björntorp P et al. (1996) Physical fitness, muscle morphology, and insulin-stimulated limb blood flow in normal subjects. Am J Physiol 270:E905-E911
27. Lindbom L (1983) Microvascular blood flow distribution in skeletal muscle. An intravital microscopic study in the rabbit. Acta Physiol Scand [Suppl] 525: 1-40
28. Steinberg HO, Brechtel G, Johnson A, Fireberg N, Baron AD (1994) Insulin-mediated skeletal muscle vasodilatation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release. J Clin Invest 94: 1172-1179
29. Chen Y-Y, Messina EJ (1996) Dilatation of isolated skeletal muscle arterioles by insulin is endothelium-dependent and nitric oxide mediated. Am J Physiol 270:H2120-H2124
30. Zeng G, Quon MJ (1996) Insulin-stimulated production of nitric oxide is inhibited by Wortmannin. Direct measurement in vascular endothelial cells. J Clin Invest 98:894-898
31. DeFronzo RA, Beckles AD (1979) Glucose metabolism following chronic metabolic acidosis in man. Am J Physiol 236:E328-E334
32. + -ATPase: mechanisms underlying rapid and sustained changes in pump activity. Am J Physiol 269:C295-C311
33. Kahn AM, Seidel CL, Allen JC, O'Neil RG, Shelat H, Song T (1993) Insulin reduces contraction and intracellular calcium concentration in vascular smooth muscle. Hypertension 22: 735-742
34. Busse R, Mülsch A, Fleming I, Hecker M (1993) Mechanisms of nitric oxide release from the vascular endothelium. Circulation 87:V-18-V-25
35. Dinerman JL, Lowenstein CJ, Synder SH (1993) Molecular mechanisms of nitric oxide regulation. Potential relevance to cardiovascular disease. Circ Res 73: 217-222
36. McKay MK, Hester RL (1996) Role of nitric oxide, adenosine, and ATP-sensitive potassium channels in insulininduced vasodilatation. Hypertension 28: 202-208
37. Scherrer U, Vollenweider P, Randin D, Jéquier E, Nicod P, Tappy L (1993) Suppression of insulin-induced sympathetic activation and vasodilation by dexamethasone in humans. Circulation 88: 388-394
38. Vollenweider P, Tappy L, Randin D et al. (1993) Differential effects of hyperinsulinemia and carbohydrate metabolism on sympathetic nerve activity and muscle blood flow in humans. J Clin Invest 92: 147-154
39. Vollenweider L, Tappy L, Owlya R, Jéquier E, Nicod P. Scherrer U (1995) Insulin-induced sympathetic activation and vasodilatation in skeletal muscle. Effects of insulin resistance in lean subjects. Diabetes 44: 641-645
40. Mäkimattila S, Virkamäki A, Malmström R, Utriainen T, Yki-Järvinen H (1996) Insulin resistance in type I diabetes mellitus: A major role for reduced glucose extraction. J Clin Endocrinol Metab 81: 707-712
41. Randin D, Vollenweider P, Tappy L, Jéquier E, Nicod P, Scherrer U (1994) Effects of adrenergic and cholinergic blockade on insulin-induced stimulation of calf blood flow in humans. Am J Physiol 266:R809-R816
42. Lembo G, Capaldo B, Rendina Vet al. (1994) Acute noradrenergic activation induces insulin resistance in human skeletal muscle. Am J Physiol 266:E242-E247
43. Berne C, Fagius J, Pollare T, Hjemdahl P (1992) The sympathetic response to euglycaemic hyperinsulinaemia. Diabetologia 35:873-879
44. Vollenweider P, Randin D, Tappy L, Jéquier E, Nicod P, Scherrer U (1994) Impaired insulin-induced sympathetic neural activation and vasodilatation in skeletal muscle in obese humans. J Clin Invest 93: 2365-2371
45. Lembo G, Napoli R, Capaldo B et al. (1992) Abnormal sympathetic overactivity evoked by insulin in the skeletal muscle of patients with essential hypertension. J Clin Invest 90: 24-29
46. Hausberg M, Mark AL, Hoffman RP, Sinkey CA, Anderson EA (1995) Dissociation of sympathoexcitatory and vasodilator actions of modestly elevated plasma insulin levels. J Hypertension 13: 1015-1021
47. Porcellati F, Fanelli C, Bottini P et al. (1993) Mechanisms of arterial hypotension after therapeutic dose of subcutaneous insulin in diabetic autonomic neuropathy. Diabetes 42: 1055-1064
48. Steinberg HO, Chaker H, Leaming R, Johnson A, Brechtel G, Baron AD (1996) Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest 97: 2601-2610
49. Castillo C, Bogardus C, Bergman R, Thuillez P, Lillioja S (1994) Interstitial insulin concentrations determine glucose uptake rates but not insulin resistance in lean and obese men. J Clin Invest 93: 10-16
50. Ferrannini E, Buzzigoli G, Bonadonna R et al. (1987) Insulin resistance in essential hypertension. N Engl J Med 317: 350-357
51. Capaldo B, Lembo G, Napoli R et al. (1991) Skeletal muscle is a primary site of insulin resistance in essential hypertension. Metabolism 40: 1320-1322
52. Dengel DR, Pratley RE, Hagberg JM, Golberg AP (1994) Impaired insulin sensitivity and maximal responsiveness in older hypertensive men. Hypertension 23: 320-324
53. Pollare T, Lithell H, Berne C (1990) Insulin resistance is a characteristic feature of primary hypertension independent of obesity. Metabolism 40: 1320-1322
54. Falkner B, Hulman S, Kusher H (1993) Insulin-stimulated glucose utilization and borderline hypertension in young adult blacks. Hypertension 22: 18-25
55. Hulthen UL, Endre T, Mattiasson I, Berglund G (1995) Insulin and forearm vasodilatation in hypertension-prone men. Hypertension 25: 214-218
56. Doria A, Fioretto P, Avogaro A et al. (1991) Insulin resistance is associated with high sodium-lithium countertransport in essential hypertension. Am J Physiol 261: E684-E691
57. O'Shaughnessy IM, Myers TJ, Stepniakowski K et al. (1995) Glucose metabolism in abdominally obese hypertensive and normotensive subjects. Hypertension 26: 186-192
58. Taddei S, Virdis A, Mattei P, Natali A, Ferrannini E, Salvetti A (1995) Effect of insulin on acetylcholine-induced vasodilatation in normotensive subjects and patients with essential hypertension. Circulation 92: 2911-2918
59. Hunter SJ, Harper R, Ennis CN, Sheridan B, Atkinson AB, Bell PM (1997) Skeletal muscle blood flow is not a determinant of insulin resistance in essential hypertension. J Hypertens 15: 73-77
60. Anderson EA, Sinkey CA, Lawton WJ, Mark AL (1989) Elevated sympathetic nerve activity in borderline hypertensive humans. Evidence from direct intraneural recordings. Hypertension 14: 177-183
61. Henrich HA, Romen W, Heimgärtner W, Harting E, Bàumer F (1988) Capillary rarefaction characteristic of the skeletal muscle of hypertensive patients. Klin Wochenschr 66: 54-60
62. Kilcoyne CM, Quyyumi AA, Cannon RO (1995) Impaired endothelium-dependent vasodilatation in patients with essential hypertension. Circulation 91: 1732-1738
63. Panza JA, Quyyumi AA, Brush JEJ, Epstein SE (1990) Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 323: 22-27
64. Natali A, Taddei S, Galvan AQ et al. (1997) Insulin sensitivity, vascular reactivity, and clamp-induced vasodilatation in essential hypertension. Circulation 96: 849-855
65. + free medium, ouabain, and insulin upon the fate of glucose in rat diaphragm. Biochim Biophys Acta 120:361-368
66. + and glucose transport in soleus muscle. Am J Physiol 252:E492-E499
67. Mäkimattila S, Virkamäki A, Groop P-H et al. (1996) Chronic hyperglycemia impairs endothelial function and insulin sensitivity via different mechanisms in insulin-dependent diabetes mellitus. Circulation 94: 1276-1282
68. Tessari P, Biolo G, Inchiostro S et al. (1990) Effects of insulin on whole body and forearm leucine and KIC metabolism in type 1 diabetes. Am J Physiol 259:E96-E103
69. Yki-Järvinen H (1992) Glucose toxicity. Endocr Rev 13: 415-431
70. Vuorinen-Markkola H, Koivisto VA, Yki-Järvinen H (1992) Mechanisms of hyperglycemia-induced insulin resistance in whole body and skeletal muscle of type 1 diabetic patients. Diabetes 41: 571-580
71. Bak JF, Moller N, Schmitz O, SaFk A, Pedersen O (1992) In vivo insulin action and muscle glycogen synthase activity in type 2 (non-insulin-dependent) diabetes mellitus: effects of diet treatment. Diabetologia 35: 777-784
72. Mandarino LJ, Consoli A, Jain A, Kelley DE (1996) Inter-action of carbohydrate and fat fuels in human skeletal muscle: impact of obesity and NIDDM. Am J Physiol 270:E463-E470
73. Kelley DE, Mandarino LJ (1990) Hyperglycemia normalizes insulin-stimulated skeletal muscle glucose oxidation and storage in noninsulin-dependent diabetes mellitus. J Clin Invest 86: 1999-2007
74. Bonadonna RC, Del Prato S, Saccomani MP et al. (1993) Transmembrane glucose transport in skeletal muscle of patients with non-insulin-dependent diabetes. J Clin Invest 92: 486-494
75. . Bonadonna RC, Del Prato S, Bonora E et al. (1996) Roles of glucose transport and glucose phosphorylation in muscle insulin resistance of NIDDM. Diabetes 45: 915-925
76. Utriainen T, Nuutila P, Takala T et al. (1997) Intact insulin stimulation of skeletal muscle blood flow, its heterogeneity and redistribution but not of glucose uptake in non-insulin-dependent diabetes mellitus. J Clin Invest 100: 777-785
77. Dela F, Larsen JJ, Mikines KJ, Ploug T, Petersen LN, Galbo H (1995) Insulin-stimulated muscle glucose clearance in patients with NIDDM. Effects of one-legged physical training. Diabetes 44: 1010-1020
78. Tack CJJ, Smits P, Willemsen JJ, Lenders JWM, Thien T, Lutterman JA (1996) Effects of insulin on vascular tone and sympathetic nervous system in NIDDM. Diabetes 45: 15-22
79. Baron AD, Laakso M, Brechtel G, Edelman SV (1991) Reduced capacity and affinity of skeletal muscle for insulin-mediated glucose uptake in non-insulin-dependent diabetes mellitus. J Clin Invest 87: 1186-1194
80. Natali A, Bonadonna R, Santoro D et al. (1994) Insulin resistance and vasodilatation in essential hypertension. Studies with adenosine. J Clin Invest 94: 1570-1576
81. Rosen P, Eckel J, Reinauer H (1983) Influence of bradykinin on glucose uptake and metabolism studied in isolated cardiac myocytes and isolated perfused rat hearts. Hoppe-Seyler's Z Physiol Chem 364: 1431-1438
82. 18F]fluoro-deoxy-glucose and positron emission tomography. J Clin Invest 97: 1741-1747
83. Jamerson JK, Nesbitt SD, Amerena JV, Grant E, Julius S (1996) Angiotensin mediates forearm glucose uptake by hemodynamic rather than direct effects. Hypertension 27: 854-858
84. Fliser D, Arnold U, Kohl B, Hartung R, Ritz E (1993) Angiotensin II enhances insulin sensitivity in healthy volunteers under euglycemic conditions. J Hypertens 11: 983-988
85. Widgren BR, Urbanavicius V, Wikstrand J, Attvall S, Persson B (1993) Low-dose angiotensin II increases glucose disposal rate during euglycemic hyperinsulinemia. Am J Hypertens 6: 892-895
86. Baron AD, Steinberg HO, Chaker H, Learning R, Johnson A, Brechtel G (1995) Insulin-mediated skeletal muscle vasodilatation contributes to both insulin sensitivity and responsiveness in lean humans. J Clin Invest 96: 786-792
87. Balon TW, Nadler JL (1994) Nitric oxide release is present from incubated skeletal muscle preparations. J Appl Physiol 77: 2519-2521
88. Clark MG, Colquhoun EQ, Rattigan S. Dora KA, Eldershaw TPD, Hall JL, Ye J (1995) Vascular and endocrine control of muscle metabolism. Am J Physiol 268:E797-E812
89. Rattigan S, Clark MG, Barrett EJ (1997) Hemodynamic actions of insulin in rat skeletal muscle. Evidence for capillary recruitment. Diabetes 46: 1381-1388
90. 15O]-labeled carbon monoxide and positron emission tomography. Am J Physiol 269:E1000-E1005
91. Vicini P, Bonadonna R, Utriainen T, Nuutila P, Yki-Järvinen H, Cobelli C (1997) Estimation of blood flow heterogeneity distribution in human skeletal muscle from posion emission tomography data. Annals of Biomedical Engineering 25: 906-910
92. Anderson TJ, Meredith IT, Charbonneau F et al. (1996) Endothelium-dependent coronary vasomotion relates to the susceptibility of LDL to oxidation in humans. Circulation 93: 1647-1650
93. Heitzer T, Ylä-Herttuala S, Luoma J et al. (1996) Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hypercholesterolemia. Circulation 93: 1346-1353
94. Casino PR, Kilcoyne CM, Quyyumi AA. Hoeg JM, Panza JA (1993) The role of nitric oxide in endothelium-dependent vasodilation of hypercholesterolemic patients. Circulation 88: 2541-2547
95. Gilligan DM, Sack MN, Guetta V et al. (1994) Effect of antioxidant vitamins on low density lipoprotein oxidation and impaired endothelium-dependent vasodilation in patients with hypercholesterolemia. J Am Coll Cardiol 24: 1611-1617
96. Craeger MA, Cooke JP, Mendelsohn ME et al. (1990) Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J Clin Invest 86: 228-234
97. Chowienczyk PJ, Watts GF, Cockroft JR, Ritter JM (1992) Impaired endothelium-dependent vasodilation of forearm resistance vessels in hypercholesterolaemia. Lancet 340: 1430-1432
98. Karhapää P, Voutilainen E, Kovanen P, Laakso M (1993) Insulin resistance in familial and nonfamilial hypercholesterolaemia. Atherosclerosis and Thrombosis 13: 41-47
99. Galvan AQ, Santoro D, Natali A et al. (1993) Insulin sensitivity in familial hypercholesterolemia. Metabolism 42: 1359-1364
100. Sheu WHH, Shieh SM, Fuh MMT et al. (1993) Insulin resistance, glucose intolerance and hyperinsulinemia. Hypertriglyceridemia versus hypercholesterolemia. Atherosclerosis and Thrombosis 13: 367-370
101. Elliot TG, Cockroft JR, Groop P-H, Viberti GC, Ritter JM (1993) Inhibition of nitric oxide synthesis in forearm vasculature of insulin dependent diabetic patients: blunted vasoconstriction in patients with microalbuminuria. Clin Sci 85: 687-693
102. Chowienczyk PJ, Watts GF (1997) Endothelial function, insulin resistance and non-insulin-dependent diabetes. Endocrinol Metab 4: 225-232
103. Pyörälä K (1979) Relationship of glucose tolerance and plasma insulin in the incidence of coronary heart disease. Results from two population studies in Finland. Diabetes Care 2: 131-141
104. Welborn TA, Wearne K (1979) Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations. Diabetes Care 2: 154-160
105. Ducimetiere P, Eschwege JL, Papoz JL et al. (1980) Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population. Diabetologia 19: 205-210
106. Jiang Z, Lin Y-W, Clermont A, Igarashi M, King G (1997) Direct demonstration of selective insulin resistance on PI3-kinase pathway in vascular tissues of obese Zucker (fa/fa) rats. Diabetes 46: 54A(Abstract)
107. Baron AD, Steinberg H, Brechtel G, Johnson A (1994) Skeletal muscle blood flow independently modulates insulin-mediated glucose uptake. Am J Physiol 266:E248-E253